Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Cefepime hcl + l ? arginine

    Product Cefepime hcl + l ? arginine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime hcl + l ? arginine. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj

    Product Cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for...
  • Cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg

    Product Cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us ...
  • Cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj

    Product Cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Cefpodoxime proxetil

    Product Cefpodoxime proxetil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefpodoxime proxetil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefprozil

    Product Cefprozil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefprozil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Product Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us fo...
  • Ceftiofur sodium sterile & ceftiofur hcl

    Product Ceftiofur sodium sterile & ceftiofur hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftiofur sodium sterile & ceftiofur hcl. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Product Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Cont...
  • Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Product Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg. It belobgs to antibacterial cephalosporins finish formulations products c...
  • Certrorelix acetate injection (0.25 / vial)

    Product Certrorelix acetate injection (0.25 / vial)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.
  • Cetrizine di hcl

    Product Cetrizine di hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrizine di hcl. It belongs toantiallergic apis category. Contact us for more information.

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)